Extensive efforts have been devoted to study A-type lamins because mutations in their gene, LMNA in humans, are associated with a number of diseases. The mouse germline mutations in the A-type lamins (encoded by Lmna) exhibit postnatal lethality at either 4 -8 postnatal (P) weeks or P16 -18 days, depending on the deletion alleles. These mice exhibit defects in several tissues including hearts and skeletal muscles. Despite numerous studies, how the germline mutation of Lmna, which is expressed in many postnatal tissues, affects only selected tissues remains poorly understood. Addressing the tissue specific functions of Lmna requires the generation and careful characterization of conditional Lmna null alleles. Here we report the creation of a conditional Lmna knockout allele in mice by introducing loxP sites flanking the second exon of Lmna. The Lmna flox/flox mice are phenotypically normal and fertile. We show that Lmna homozygous mutants (Lmna / ) generated by germline Cre expression display postnatal lethality at P16 -18 days with defects similar to a recently reported germline Lmna knockout mouse that exhibits the earliest lethality compared to other germline knockout alleles. This conditional knockout mouse strain should serve as an important genetic tool to study the tissue specific roles of Lmna, which would contribute toward the understanding of various human diseases associated with A-type lamins.
Introduction
The nuclear lamina (NL) is a meshwork of proteins that lines the inner nuclear membrane and serves as a nuclear scaffold. Lamins, which belong to the type V intermediated filaments, are the major components of the NL. Lamin proteins were initially subdivided based on immunological and biochemical criteria [1, 2] . A-type lamins have nearly neutral isoelectric points (pI) and are almost completely solubilized during mitosis, whereas B-type lamins have acidic pI and remain associated with nuclear envelope derived membranes during mitosis. Since the first cDNA cloning of A-type lamins in humans [3] , lamins have been identified in many vertebrates. Sequence comparisons of lamin proteins have revealed that despite of overall similarity, A-and B-type lamins exhibit subclass-specific sequence variations [4, 5, 6] . It is also known that both A and B-type lamins are initially carboxymethylated and farnesylated at the C-terminal CaaX motif, but these modifications are removed from lamin-A by proteolysis (reviewed in [7] ).
In the mouse, Lmnb1 and Lmnb2 encode lamin-B1 and lamin-B2, respectively. Lmnb2 also expresses lamin-B3 through alternatively splicing in the testes. On the other hand, Lmna expresses several forms of A-type lamins, including lamin-A, -C, -A 10, and -C2, via alternative splicing. While B-type lamins are expressed in most cell types throughout development, the expression of A-type lamins is either lacking or very low during early development with increasing levels of expression in some cell types as development progresses [8, 9, 10] . For example, during mouse embryogenesis, the expression of A-type lamins is limited to a few tissues such as the trunk and epidermis, while in many other tissues, lamin-A/C is not detected until well after birth. In adult mice, lamin-A/C are expressed in many tissues at high levels [9] .
Since the discovery that mutations in LMNA cause autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD) in humans [11] , many additional LMNA mutations have been shown to cause a large group of human diseases ranging from muscular dystrophy to premature aging disease. Several germline Lmna mutant mouse models have been generated with the aim of understanding the mechanisms by which A-type lamins function in health and diseases [12, 13] . Sullivan and colleagues showed that homozygous mice deleted of exon 8 -11 of Lmna (referred to here as Lmna 8-11/ 8-11 ) in the germline develop to term with no overt abnormalities [14] . However, their postnatal growths are severely retarded, and these mice present with a subset of pathologies similar to those caused by LMNA mutations, including muscular dystrophy, dilated cardiomyopathy, and Charcot-Marie-Tooth syndrome in humans [15] . These mice die at around 4 -8 weeks after birth. Despite the widespread use of this mouse model, recent studies show that these mice still express a truncated lamin-A protein of 54 kDa, which corresponds to the 468 amino acids encoded by exon 1 -7 and 12, through alternative splicing [16] . The expression of this large lamin-A fragment might function dominant negatively because heterozygous Lmna +/ 8-11 mice develop dilated cardiomyopathies 4 weeks after birth [17] , which complicates phenotypic interpretation.
Recently, another Lmna germline knockout mouse line has been created using gene trap (GT) technology [13] . In the Lmna GT−/− mouse, a gene trap cassette, consisting of a splicing acceptor and a reporter gene, is introduced into the upstream sequence of exon 2 of Lmna, and only the N-terminal 118 amino acids of lamin-A is expressed as a fusion with the reporter protein. Lmna GT−/− mice are overtly normal during embryogenesis. However, they succumb to death at 16 -18 days after birth, which is much earlier than Lmna 8-11/ 8-11 mice. Therefore, Lmna GT−/− mice are the most severe loss-of-function mutants for A-type lamins to date.
Although mutations of LMNA are associated with diverse human diseases, a careful look at the diseases and animal models reveals that the defects caused by different mutations are manifested in limited tissue types including striated muscles, adipose tissues, and peripheral nerves [18] . How mutations in the broadly expressed lamin-A cause tissue-restricted defects is unclear. Several nonexclusive hypotheses have been proposed to account for the molecular basis of this selectivity [19] . For example, the mechanical stress model posits that cell types such as muscle cells that are under constant mechanical stress might be more susceptible to the alteration of the nuclear lamina [20] . The gene expression model, on the other hand, proposes that lamins influence gene expression profiles in a cell type specific manner [21, 22] . Although studies using the germline Lmna mutant mouse models created thus far have provided support to aspects of the above hypotheses, understanding the function of Lmna in a given tissue requires the creation of a conditional Lmna knockout allele. Recently, Solovei et al. reported the use of an Lmna conditional knockout allele, which leads to the deletion of the last three exons (exons 10 -12) of Lmna upon Cre expression [23] . The predicted lack of polyA signal in Lmna transcripts from exons 1 to 9 may cause their degradation. However, these transcripts could utilize a cryptic polyA signal in the absence of exons 10 -12, which would lead to the generation of truncated lamin-A/C proteins. Unfortunately, the authors provided no characterization of this Lmna conditional knockout allele. Thus it remains unclear whether truncated lamin-A/C proteins are present upon Cre expression in these mice. To facilitate the study of the tissue autonomous function of A-type lamins, we report the generation and characterization of a different conditional Lmna knockout mouse model that deletes the majority of lamin-A/C proteins upon Cremediated recombination.
Materials and methods

Construction of the targeting vector
The targeting vector to generate conditional knockout alleles of Lmna was constructed using the recombineering protocol established by the Capecchi laboratory [24] . Briefly, an 8kb genomic region from 2 kb upstream of exon 2 through the middle of exon 11 of Lmna was retrieved from a mouse BAC clone RP24-265E18, and was cloned into the pStart-K vector using Red-recombinase mediated cloning method. The construct was modified to add the 5 and 3 loxP sites at 100 bp upstream and downstream, respectively, from exon 2 of Lmna by a series of conventional and recombination-mediated cloning. The resulting plasmid was cut between exon 2 and the 3 loxP site with the restriction enzyme MluI and ligated to an Frtpuro-Frt cassette flanked by MluI sites to obtain a positive selection marker. Finally, the modified genomic fragment of Lmna in the pStart-K vector was transferred by Gateway recombination to the pWS-TK6 vector containing a thymidine kinase (tk) cassette as a negative selection marker. Full DNA sequences of the Lmna targeting vector were verified by conventional DNA sequencing, and are available upon request. All procedures involving recombinant DNA have followed the National Institute of Health guidelines.
PCR primers and mouse strains
To generate the Lmna fflox allele, the Lmna targeting vector was linearized by AsiSI and introduced into V6.5 mouse ESCs by electroporation. After selection with 1 g/ml puromycin (Life Technologies) and 2 M ganciclovir (Sigma, G2536), ESC clones were screened for homologous recombination by long-range PCR of the flanking regions of the 5 and 3 recombination arms from the genomic DNA. The PCR primers used to screen for the homologously recombined ESC clones are as follows:
To generate Lmna flox allele in which the puromycin cassette flanked by Frt sites is deleted, Lmna fflox/+ mice were bred with ACTB-FLPe mice (#003800, JAX lab), which express a variant of FLP1 recombinase with enhanced thermal stability in a wide variety of tissues including germ cells. Lmna flox/+ mice were identified by PCR of the flanking region of exon 2 of Lmna. PCR primers used to genotype all possible Lmna alleles in the resulting offspring are as follows:
Lmna flox/+ mice were intercrossed to generate Lmna flox/flox mice, and maintained in a mixed genetic background from CD1, 129Sv, and C57Bl/6J strains.
To generate the Lmna allele, Lmna flox/+ mice were bred with CMV-Cre mice (#003465, JAX lab). The generation of Lmna allele in the F1 generation of Lmna flox/+ × CMV-Cre mating pairs were screened by PCR of tail DNA with the primer pair P3F/R. CMV-Cre allele was genotyped according to the PCR protocol for generic Cre from the Jackson Laboratory. To remove the CMV-Cre allele present in the F1 generation, Lmna /+ ; CMVCre +/− mice were outcrossed with 129S6/SvEvTac (Taconic). Lmna /+ mice in the F2 generation that did not express Cre recombinase were used to generate the Lmna / mice analyzed in this study. Lmna +/+ , Lmna /+ , and Lmna / mice were genotyped by PCR with the primer pair P3F/R. Mice used in this study are available upon request.
Isolation of MEFs
MEFs were generated by a standard protocol. Briefly, embryos were collected from the uteri of pregnant mice at embryonic day 13.5. The heads, visceral tissues and gonads of embryos were removed. The remaining embryonic bodies were minced and trypsinized twice. Fibroblasts from each embryo were harvested by centrifugation and then plated in MEF medium [15% FBS, 100 M -mercaptoethanol, 2 mM L-glutamine, 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, 50 g/ml penicillin/streptomycin in Knockout DMEM (Life Technologies)]. Passage 1 MEFs were used for immunofluorescence staining and Western blotting analysis. Genomic DNA isolated from embryo heads were used for PCR genotyping.
Antibodies, Western blotting, and immunofluorescence staining
Western blotting analysis was performed as described [25] . Monoclonal mouse anti-lamin-A/C (Active Motif 39287, 1:1000), goat anti-lamin-B1 (Santa Cruz sc-6216, 1:200), and monoclonal mouse anti--tubulin (Sigma T9026, 1:5000) were used as the primary antibodies. The monoclonal anti-lamin-A/C antibody used in this study was raised against a recombinant protein corresponding to amino acids 430 -545 of human amin-A. Anti-mouse IgG HRP and anti-goat IgG HRP (Pierce) were used as secondary antibodies. Immunofluorescence staining was performed as described [25] . Mouse anti-lamin-A/C (Active Motif 39287, 1:1000) and donkey anti-mouse IgG DyLight 488 were used as primary and secondary antibodies, respectively.
Histology
Tibialis anterior (TA) muscles were dissected from 15 day old mice, snap frozen, and sectioned at 10 m thickness by a Leica CM3000 Cryostat. Sectioned TA muscles were used for either immunofluorescence staining for lamin-A/C or haematoxylin and eosin (H&E) staining after washing with PBS. Immunofluorescence and H&E staining were performed as described [25] .
Quantitation of myofibril size
Cross-sectioned TA muscles were stained by H&E. Digital images were acquired with a CCD camera by routine bright field microscopy. Myofibrils were individually delineated by Photoshop software, and the area of each myofibril was determined by counting pixels. To convert to m 2 units, pixel numbers of myofibrils were normalized by those of unit area measured by the scale bar.
Results and Discussion
Generation of Lmna fflox/+ , Lmna flox/+ , and Lmna flox/flox mice Wild-type Lmna allele consists of 12 exons, which encode 665 amino acids, and an alternative first exon, 1c, that contributes to 7 amino acids at the N-terminus of lamin-C2 (Fig. 1A) . Exon 1 and 1c of Lmna are separated by an intronic region of over 9 kb, which could make the deletion of the two exons inefficient. This would be undesirable for a conditional allele. Therefore, to remove all isoforms of lamin-A including lamin-C2, we set out to create a conditional exon 2 deletion allele. We constructed a targeting vector in which exon 2 of Lmna is flanked by loxP and Frt-Puro-Frt-loxP (Fig. 1B) . The Lmna targeting vector was introduced into the V6.5 mouse embryonic stem cells (ESC) to replace exon 2 of Lmna with the chimeric sequences in the vector by homologous recombination (Fig. 1A and   1B ). After positive and negative selections with puromycin and ganciclovir, respectively, we screened ESC clones for homologous recombination at both the 5 and 3 arms by longrange PCR using the P1F/R and P2F/R primer pairs (data not shown). We named this allele, which still has Frt-puro-Frt cassette, as Lmna fflox (Fig. 1C) to distinguish it from the further processed Lmna alleles.
The selected ESC clone containing the Lmna fflox allele was injected into blastocysts to generate chimeras as previously described [25] . Male chimeras were bred with CD1 females to examine germline transmission of the Lmna fflox allele. The presence of the Lmna fflox allele in agouti F1 mice was verified by long-range PCR of tail DNA using the P1F/R and P2F/R primer pairs ( Fig. 1E and 1F) . To generate the Lmna flox allele in which the puromycin cassette flanked by Frt sites is cleaved, Lmna fflox/+ mice were bred with ACTBFLPe mice, which express FLP1 recombinase under the control of the human -actin promoter (Fig. 1D) . The Lmna flox/+ offspring in the next generation were identified by PCR of the flanking regions of exon 2 of Lmna using the P3F/R primer pair (Fig. 1G) . To generate homozygous Lmna flox/flox mice, Lmna flox/+ mice were intercrossed. We found that both Lmna flox/+ and Lmna flox/flox mice were viable and fertile, and did not display any recognizable phenotypes, suggesting that the Lmna flox allele does not lead to gain or loss of functions.
Generation of Lmna Δ/+ and Lmna Δ/Δ mice
To examine whether the Lmna flox allele generates a loss-of-function allele for Lmna upon the expression of Cre recombinase, we set out to analyze Lmna / mice in which the 357 bp fragment including exon 2 of Lmna is deleted in the entire animals. To create the Lmna allele, Lmna flox/+ mice were bred with CMV-Cre mice that express Cre recombinase under control of the CMV promoter in all tissues including the germ cells ( Fig. 2A) . PCR of tail DNA with the primer pair P3F/R confirmed the generation of the Lmna allele in the F1 generation of Lmna flox/+ × CMV-Cre mating pairs (Fig. 2B) . The CMV-Cre allele was then removed by breeding to ensure stable transmission of the Lmna allele to the next generation in the absence of CMV-Cre. Heterozygous Lmna /+ mice were phenotypically normal and fertile. We intercrossed Lmna /+ mice to generate homozygous Lmna / mice. In Lmna / mice deleted of both copies of exon 2, exon 1 or 1c may undergo cryptic splicing with remaining downstream exons, generating chimeric proteins. We examined this possibility by Western blotting with an antibody raised against the C-terminus of lamin-A proteins. Cell lysates prepared from mouse embryonic fibroblasts (MEFs) indicated that the Lmna / cells expressed neither intact nor truncated forms of lamin-A/C proteins (Fig. 2C) . Loss of lamin-A/C in Lmna / cells was further confirmed by immunofluorescence staining of MEFs with the anti-lamin-A/C antibody (Fig. 2D) . These analyses show that deleting the exon 2 indeed generates a most severe loss-of-function allele for Lmna reported to date.
Lmna Δ/Δ mice exhibit severe postnatal defects
To further validate whether Lmna allele is functionally inactive, we analyzed Lmna / mice obtained by intercrossing Lmna /+ mice. At birth, pups of all genotypes including Lmna / are viable (Table 1 ) and display no recognizable defect. However, the growth of Lmna / mouse was severely retarded after birth compared to Lmna +/+ or Lmna /+ mice as judged by body weight measurement (Fig. 3A) . The body weights of the Lmna / mice peaked at around postnatal day 12 and it slightly decreased thereafter. By postnatal day 14 Lmna / mice had only ~53% of the body weight of Lmna +/+ or Lmna /+ littermates (Fig.  3B) . Lmna / mice invariably died between postnatal days 16 to 18 ( Table 1 ). These defects of Lmna / mice are very similar to those of Lmna GT−/− mice reported [13] , but are more severe than those of the incomplete Lmna 8-11/ 8-11 mice [14] .
The germline knockout mice displayed defects in a range of tissues with skeletal muscles being the most severely impaired [13, 14] . We did pathology examinations of skeletal muscles to test whether Lmna / mice recapitulate the defects of the germline knockout mice reported previously. Immunostaining of skeletal muscle sections from tibialis anterior (TA) confirmed that Lmna / mice did not express lamin-A/C (Fig. 3C) . Histological examination of TA muscles revealed that the skeletal myofibrils of Lmna / mice are smaller than those of Lmna +/+ littermates at postnatal day 15 ( Fig. 3D and 3E ). This defect is quite similar to those observed in Lmna GT−/− mice [13] . Together, the above characterizations of Lmna / mice show that the Lmna flox allele we have created can be utilized to generate the Lmna loss-of-function allele in spatially and temporally controlled manners.
Conditional knockout alleles are critical for dissecting tissue and cell type specific functions for a given protein. Considering the tissue restricted defects for lamin-A/C mutations, it is critical to decipher the cell-specific functions of lamin-A/C during development and homeostasis. Ideal Lmna conditional alleles should not express any lamin-A/C proteins including truncated isoforms upon Cre expression. Our characterizations show that Cremediated deletion of exon 2 of Lmna resulted in no detectable expression of the intact form or C-terminus of lamin-A/C as judged by the available antibodies. We also report that the mice deleted of exon 2 of Lmna are phenotypically similar to Lmna GT−/− mice, which is currently the most severe loss-of-function Lmna mutant [13] . Therefore, the new conditional Lmna knockout mouse and cells reported here provide a great tool to better define lamin-A/ C's functions in specific tissues and cell types, which should contribute toward a better understanding of genetic disorders associated with the nuclear lamina. Additionally, by combining with the established conditional knockout mice for lamin-B1 and -B2 [26] , it is now possible to deplete all lamins in a spatially and temporally controlled manner in order to define the functions of these important nuclear lamina proteins.
*Highlights
A new Lmna conditional knockout allele (KO) deletes exon 2 upon Cre expression.
Mice deleted of exon 2 by germline Cre expression phenocopy conventional Lmna KO mice.
The new Lmna conditional KO mouse is a useful tool to examine the tissue specific role of A-type lamins. 
